Insider Transaction: Philip W. Kantoff Acquires Stock Options in Context Therapeutics Inc.

Philip W. Kantoff, a director at Context Therapeutics Inc. (CNTX), acquired 45,000 stock options on June 24, 2026. These options, with an exercise price of $0.576, are for the company's Common Stock and have an expiration date of June 23, 2036. The options vest and become exercisable on the earlier of June 24, 2027, or the company's 2027 annual meeting of stockholders, contingent upon continued service with the issuer. This transaction is reported on Form 4 and is classified as an officer or director change, though Mr. Kantoff is a director and not an officer. The filing indicates no other non-derivative or derivative transactions.